|
ACLY expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.649900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.360120E-02 |
| Normal-vs-Stage2 |
2.146100E-02 |
| Normal-vs-Stage3 |
3.894400E-02 |
| Normal-vs-Stage4 |
2.288000E-02 |
| Stage1-vs-Stage2 |
5.741200E-01 |
| Stage1-vs-Stage3 |
7.894200E-01 |
| Stage1-vs-Stage4 |
7.308200E-01 |
| Stage2-vs-Stage3 |
6.714600E-01 |
| Stage2-vs-Stage4 |
9.306600E-01 |
| Stage3-vs-Stage4 |
7.940400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.848830E-04 |
| Normal-vs-AfricanAmerican |
3.339800E-01 |
| Normal-vs-Asian |
3.104400E-01 |
| Caucasian-vs-AfricanAmerican |
5.864000E-03 |
| Caucasian-vs-Asian |
6.526600E-01 |
| AfricanAmerican-vs-Asian |
6.844200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.641000E-03 |
| Normal-vs-Female |
1.418430E-04 |
| Male-vs-Female |
2.647600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.172100E-02 |
| Normal-vs-Extreme_Weight |
3.668500E-02 |
| Normal-vs-Obese |
7.741100E-03 |
| Normal-vs-Extreme_Obese |
5.770200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.975400E-01 |
| Normal_Weight-vs-Obese |
2.956400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.156200E-01 |
| Extreme_Weight-vs-Obese |
2.714800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.478400E-01 |
| Obese-vs-Extreme_Obese |
3.875400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.039500E-03 |
| Normal-vs-Age(41-60Yrs) |
9.89999999999602E-05 |
| Normal-vs-Age(61-80Yrs) |
1.145850E-01 |
| Normal-vs-Age(81-100Yrs) |
5.680800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.656000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.699400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.933500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.663300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.600160E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.233400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.244200E-03 |
| Normal-VS-Type2 PRCC |
2.339800E-02 |
| Normal-VS-KIRP CIMP |
2.790400E-02 |
| Normal-VS-Unclassified PRCC |
2.692200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.283000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.397800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.292200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.017000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.275400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.006500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.229800E-02 |
| Normal-vs-N1 |
1.214280E-02 |
| Normal-vs-N2 |
1.164190E-01 |
| N0-vs-N1 |
5.964000E-01 |
| N0-vs-N2 |
1.056640E-01 |
| N1-vs-N2 |
4.403700E-02 |
|
|
